These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23443340)

  • 1. Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Brkovic V; Dobric M; Beleslin B; Giga V; Vukcevic V; Stojkovic S; Stankovic G; Nedeljkovic MA; Orlic D; Tomasevic M; Stepanovic J; Ostojic M
    Int J Cardiovasc Imaging; 2013 Aug; 29(6):1215-28. PubMed ID: 23443340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
    Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI.
    Méndez-Eirín E; Flores-Ríos X; García-López F; Pérez-Pérez AJ; Estévez-Loureiro R; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos RA; Vázquez Rodríguez JM; Vázquez-González N; Castro-Beiras A
    Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):227-33. PubMed ID: 22281285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SYNTAX score: an independent predictor of long-term cardiac mortality in patients with acute ST-elevation myocardial infarction.
    Yang CH; Hsieh MJ; Chen CC; Chang SH; Wang CY; Lee CH; Hsieh IC
    Coron Artery Dis; 2012 Nov; 23(7):445-9. PubMed ID: 22968215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial SYNTAX score predicts major adverse cardiac events after primary percutaneous coronary intervention.
    Brown AJ; McCormick LM; Gajendragadkar PR; Hoole SP; West NE
    Angiology; 2014 May; 65(5):408-12. PubMed ID: 23574751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction.
    Littnerova S; Kala P; Jarkovsky J; Kubkova L; Prymusova K; Kubena P; Tesak M; Toman O; Poloczek M; Spinar J; Dusek L; Parenica J
    PLoS One; 2015; 10(4):e0123215. PubMed ID: 25893501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the SYNTAX score II to predict 1-year outcome in patients with primary percutaneous coronary intervention.
    Wang G; Wang C; Zhang Y; Wang P; Ran C; Zhao L; Han L
    Coron Artery Dis; 2016 Sep; 27(6):483-9. PubMed ID: 27171362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease.
    Onuk T; Güngör B; İpek G; Karataş MB; Çanga Y; Akyüz Ş; Haci R; Karadeniz FÖ; Sungur A; Kaşikçioğlu H; Çam N
    Coron Artery Dis; 2016 Jun; 27(4):311-8. PubMed ID: 26945185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Lev EI; Kornowski R; Vaknin-Assa H; Porter A; Teplitsky I; Ben-Dor I; Brosh D; Fuchs S; Battler A; Assali A
    Am J Cardiol; 2008 Jul; 102(1):6-11. PubMed ID: 18572028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of dedicated risk scores in patients undergoing primary percutaneous coronary intervention in daily clinical practice.
    Abelin AP; David RB; Gottschall CA; Quadros AS
    Can J Cardiol; 2014 Jan; 30(1):125-31. PubMed ID: 24238848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Predictive Roles of Risk Scores of In-Hospital Major Adverse Cardiovascular Events in Patients with Non-ST Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Aktürk E; Aşkın L; Taşolar H; Türkmen S; Kaya H
    Med Princ Pract; 2018; 27(5):459-465. PubMed ID: 29672288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRACE, TIMI, Zwolle and CADILLAC risk scores--do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively?
    Kozieradzka A; Kamiński KA; Maciorkowska D; Olszewska M; Dobrzycki S; Nowak K; Kralisz P; Prokopczuk P; Musial WJ
    Int J Cardiol; 2011 Apr; 148(1):70-5. PubMed ID: 19923016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACEF performed better than other risk scores in non-ST-elevation acute coronary syndrome during long term follow-up.
    Kristić I; Crnčević N; Runjić F; Čapkun V; Polašek O; Matetic A; Vrsalovic M
    BMC Cardiovasc Disord; 2021 Feb; 21(1):70. PubMed ID: 33535979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy.
    Yadav M; Généreux P; Palmerini T; Caixeta A; Madhavan MV; Xu K; Brener SJ; Mehran R; Stone GW
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):1-10. PubMed ID: 24408084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
    Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk score comparison of outcomes in patients presenting with ST-elevation myocardial infarction treated with percutaneous coronary intervention.
    Scruth EA; Cheng E; Worrall-Carter L
    Eur J Cardiovasc Nurs; 2013 Aug; 12(4):330-6. PubMed ID: 22694809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the TIMI, GRACE, PAMI and CADILLAC risk scores for prediction of long-term cardiovascular outcomes in Taiwanese diabetic patients with ST-segment elevation myocardial infarction: From the registry of the Taiwan Society of Cardiology.
    Kao YT; Hsieh YC; Hsu CY; Huang CY; Hsieh MH; Lin YK; Yeh JS
    PLoS One; 2020; 15(2):e0229186. PubMed ID: 32053694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.